Cravath’s London Office Moves to 100 Cheapside
Sharonmoyee Goswami focuses her practice on intellectual property, antitrust and other litigation involving complex technical and scientific issues. She represents companies and individuals in all stages of litigation, from pre‑complaint investigation through appeal, and routinely practices before the Federal Circuit and Patent Trial and Appeal Board (PTAB).
With an “exceptional ability to parse complex legal and scientific details, translating them into arguments that resonate with judges, opposing counsel, and stakeholders alike,” Ms. Goswami draws on her extensive expertise to help companies address legal issues that arise during product development and commercialization. (The Legal 500 US)
Ms. Goswami regularly leads patent infringement litigation across various industries—including life sciences, technology and financial services—and has deep experience in intellectual property strategy and management. In recognition of this work, IAM Patent 1000 points to her “exceptional command of the law, technical dexterity, intellect and positivity.” The publication has also noted that she is “extremely strategic and detail‑oriented and knows how to position cases to maximise chances of success.”
Ms. Goswami’s notable representations include:
Representing Ingevity in its appeal to the Federal Circuit of a patent infringement case against BASF and BASF’s antitrust counterclaims.
Representing Medytox in its appeal to the Federal Circuit of the final determination issued by the ITC in an action against Hugel, a global medical aesthetics company.
Representing First Solar as plaintiff in patent infringement litigation against JinkoSolar (“Jinko”), a Chinese solar module manufacturer, and its subsidiaries alleging Jinko has violated one of First Solar’s patents for TOPCon solar technology.
Secured favorable settlements for Truist Bank in patent infringement litigation brought by United Services Automobile Association (“USAA”) in Texas federal court concerning patents that relate to remote check deposits for mobile banking, and in associated IPR proceedings.
Represented Amgen in litigation concerning its introduction of a biosimilar to AbbVie’s biologic drug, Humira®—one of the world’s largest‑selling drugs—in one of the first cases to proceed under the BPCIA. Amgen reached a global settlement with AbbVie that enabled Amgen to market the first approved biosimilar to Humira® in the U.S. and Europe.
Won a jury verdict for Amgen in a patent infringement case in Delaware federal court against Sanofi and Regeneron relating to Amgen’s patents covering a class of biologic drugs that treat high cholesterol.
Obtained a jury verdict for DRIT, an investment partnership, in a patent licensing dispute against Glaxo Group over the lupus drug Benlysta®.
Ms. Goswami serves as a Vice Chair of the Federal Circuit Bar Association’s PTAB and Trademark Trial and Appeal Board (TTAB) Committee, and has previously served as Chair of the Patents Committee of the New York City Bar Association and on Law360’s Life Sciences Editorial Advisory Board. She is a member of the Diversity Committee of the PTAB Bar Association and a Director of the South Asian Bar Association of New York.
Ms. Goswami has been recognized by numerous publications. In 2024, The American Lawyer named her a finalist for its “Young Lawyer of the Year—Litigation” award. She was named a 2023 "Rising Star" by The New York Law Journal, and Benchmark Litigation has recognized her as a "Future Star" and named her to its “40 & Under List.” For her "deep grasp of complex patents" in patent litigation work, Ms. Goswami has been ranked by Chambers USA as a leading intellectual property lawyer and repeatedly recognized by IAM Patent 1000 and The Legal 500 US, including as a “Next Generation Partner.” She has also been named to Lawdragon’s “500 Leading Global IP Lawyers,” “500 Leading Litigators in America” and “500 X – The Next Generation” lists. In 2022, Ms. Goswami received LMG Life Sciences’ “US Rising Star – Intellectual Property” award and Euromoney Legal Media Group’s Rising Star Award for “Best in Patent,” and she was named to Patexia Insight’s list of Top IPR Attorneys of 2022.
Ms. Goswami was born in Washington, D.C. She received a B.S.E. in Chemical Engineering from Princeton University in 2009 and obtained certificates (minors) in Engineering Biology and Materials Science. At Princeton, she was awarded the inaugural leadership prize in Materials Science and Engineering. She received a J.D. magna cum laude from New York University School of Law in 2012, where she was a Florence Allen Scholar, a Senior Editor of the Journal of Intellectual Property & Entertainment Law and was elected to the Order of the Coif. At NYU, she was awarded the Walter J. Derenberg Prize in Copyright Law. She also received the Sidney B. Williams, Jr. scholarship from the Foundation for Advancement of Diversity in IP Law.
Ms. Goswami joined Cravath in 2012. She served as a law clerk to Hon. Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit in 2013. She rejoined Cravath in 2014 and was elected a partner in 2019. Ms. Goswami is a partner liaison to the South Asian Affinity Group.
Ms. Goswami regularly leads patent infringement litigation across various industries—including life sciences, technology and financial services—and has deep experience in intellectual property strategy and management. In recognition of this work, IAM Patent 1000 points to her “exceptional command of the law, technical dexterity, intellect and positivity.” The publication has also noted that she is “extremely strategic and detail‑oriented and knows how to position cases to maximise chances of success.”
Ms. Goswami’s notable representations include:
Representing Ingevity in its appeal to the Federal Circuit of a patent infringement case against BASF and BASF’s antitrust counterclaims.
Representing Medytox in its appeal to the Federal Circuit of the final determination issued by the ITC in an action against Hugel, a global medical aesthetics company.
Representing First Solar as plaintiff in patent infringement litigation against JinkoSolar (“Jinko”), a Chinese solar module manufacturer, and its subsidiaries alleging Jinko has violated one of First Solar’s patents for TOPCon solar technology.
Secured favorable settlements for Truist Bank in patent infringement litigation brought by United Services Automobile Association (“USAA”) in Texas federal court concerning patents that relate to remote check deposits for mobile banking, and in associated IPR proceedings.
Represented Amgen in litigation concerning its introduction of a biosimilar to AbbVie’s biologic drug, Humira®—one of the world’s largest‑selling drugs—in one of the first cases to proceed under the BPCIA. Amgen reached a global settlement with AbbVie that enabled Amgen to market the first approved biosimilar to Humira® in the U.S. and Europe.
Won a jury verdict for Amgen in a patent infringement case in Delaware federal court against Sanofi and Regeneron relating to Amgen’s patents covering a class of biologic drugs that treat high cholesterol.
Obtained a jury verdict for DRIT, an investment partnership, in a patent licensing dispute against Glaxo Group over the lupus drug Benlysta®.
Ms. Goswami serves as a Vice Chair of the Federal Circuit Bar Association’s PTAB and Trademark Trial and Appeal Board (TTAB) Committee, and has previously served as Chair of the Patents Committee of the New York City Bar Association and on Law360’s Life Sciences Editorial Advisory Board. She is a member of the Diversity Committee of the PTAB Bar Association and a Director of the South Asian Bar Association of New York.
Ms. Goswami has been recognized by numerous publications. In 2024, The American Lawyer named her a finalist for its “Young Lawyer of the Year—Litigation” award. She was named a 2023 "Rising Star" by The New York Law Journal, and Benchmark Litigation has recognized her as a "Future Star" and named her to its “40 & Under List.” For her "deep grasp of complex patents" in patent litigation work, Ms. Goswami has been ranked by Chambers USA as a leading intellectual property lawyer and repeatedly recognized by IAM Patent 1000 and The Legal 500 US, including as a “Next Generation Partner.” She has also been named to Lawdragon’s “500 Leading Global IP Lawyers,” “500 Leading Litigators in America” and “500 X – The Next Generation” lists. In 2022, Ms. Goswami received LMG Life Sciences’ “US Rising Star – Intellectual Property” award and Euromoney Legal Media Group’s Rising Star Award for “Best in Patent,” and she was named to Patexia Insight’s list of Top IPR Attorneys of 2022.
Ms. Goswami was born in Washington, D.C. She received a B.S.E. in Chemical Engineering from Princeton University in 2009 and obtained certificates (minors) in Engineering Biology and Materials Science. At Princeton, she was awarded the inaugural leadership prize in Materials Science and Engineering. She received a J.D. magna cum laude from New York University School of Law in 2012, where she was a Florence Allen Scholar, a Senior Editor of the Journal of Intellectual Property & Entertainment Law and was elected to the Order of the Coif. At NYU, she was awarded the Walter J. Derenberg Prize in Copyright Law. She also received the Sidney B. Williams, Jr. scholarship from the Foundation for Advancement of Diversity in IP Law.
Ms. Goswami joined Cravath in 2012. She served as a law clerk to Hon. Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit in 2013. She rejoined Cravath in 2014 and was elected a partner in 2019. Ms. Goswami is a partner liaison to the South Asian Affinity Group.
Federal Circuit Bar Association, PTAB and TTAB Committee
New York City Bar Association, Patents Committee
PTAB Bar Association, Diversity Committee
South Asian Bar Association of New York
Law360
The American Lawyer
Benchmark Litigation
Chambers USA
Euromoney Legal Media Group
Intellectual Asset Management
Lawdragon
The Legal 500 US
New York Law Journal
Deals & Cases
October 17, 2024
On October 15, 2024, the United States Court of Appeals for the Federal Circuit affirmed an inter partes review (“IPR”) decision by the Patent Trial and Appeal Board (“PTAB”) in favor of Cravath client ADT Inc., invalidating all claims of a patent at issue in litigation brought by Vivint, Inc.
Activities
June 30, 2025
On June 20, 2025, Cravath partner Sharonmoyee Goswami participated in the 2025 SABA North American Annual Conference, an annual gathering of South Asian attorneys, judges, general counsel, law firm leaders and public officials, which was hosted by the South Asian Bar Association of North America from June 19‑22 in Denver, Colorado. Sharon spoke on a panel entitled “Mastering Expert Testimony in Patent Trials: Strategies for Persuasion and Clarity Before a Jury,” where she also demonstrated a mock direct and redirect examination of a technical expert.
Activities
May 08, 2025
On May 7, 2025, Cravath partner Sharonmoyee Goswami participated in the 7th annual Life Sciences Patent Network North America–Spring Conference, which was hosted by Life Sciences Intellectual Property Review from May 6‑7 in Boston. The conference hosted law firms, in‑house patent counsel and executives from pharmaceutical and biotech companies to discuss the latest legal rulings, legislative changes and strategic approaches transforming the life sciences IP landscape. Sharon spoke on a panel entitled “Patenting Women’s Health: The Rise of Femtech,” which reviewed topics about patenting products and services designed to support women’s health, including how to overcome eligibility hurdles for biomarkers and addressing divided infringement issues for diagnostics.
Activities
April 25, 2025
On April 25, 2025, Cravath partners Sasha Rosenthal‑Larrea and Sharonmoyee Goswami participated in Fordham Law School’s 32nd Annual Intellectual Property Law & Policy Conference, which took place from April 24‑25 in New York. The conference convened experts across the public and private sectors to discuss developments in the IP law and policy space. Sasha spoke on a panel entitled “Artificial Intelligence” during a session on copyright law, and Sharon spoke on a panel entitled “Patents & Remedies” during a session on patent law.
Activities
April 15, 2025
On April 3, 2025, Cravath partner Sharonmoyee Goswami led “Protect, Scale, Invest: The IP Playbook for Sustainability Leaders,” an event co‑hosted by Cravath in New York. Sharon was featured in a fireside chat for a discussion on strategically leveraging intellectual property to drive value and protect innovation in the energy transition market, including optimizing IP portfolios, scaling innovation in an evolving regulatory landscape, handling potential IP litigation, navigating IP risks and opportunities in transactions and understanding legal and economic trends.
Activities
March 31, 2025
On March 24, 2025, Cravath partner Sharonmoyee Goswami participated in the Banbury Center at Cold Spring Harbor Laboratory’s Government Challenges to U.S. Patent Rights meeting, which was held from March 23‑26 in Lloyd Harbor, New York. Sharon co‑chaired a session entitled “The Public & Private Sectors - Research Funding.”
Sharonmoyee Goswami focuses her practice on intellectual property, antitrust and other litigation involving complex technical and scientific issues. She represents companies and individuals in all stages of litigation, from pre‑complaint investigation through appeal, and routinely practices before the Federal Circuit and Patent Trial and Appeal Board (PTAB).
With an “exceptional ability to parse complex legal and scientific details, translating them into arguments that resonate with judges, opposing counsel, and stakeholders alike,” Ms. Goswami draws on her extensive expertise to help companies address legal issues that arise during product development and commercialization. (The Legal 500 US)
Ms. Goswami regularly leads patent infringement litigation across various industries—including life sciences, technology and financial services—and has deep experience in intellectual property strategy and management. In recognition of this work, IAM Patent 1000 points to her “exceptional command of the law, technical dexterity, intellect and positivity.” The publication has also noted that she is “extremely strategic and detail‑oriented and knows how to position cases to maximise chances of success.”
Ms. Goswami’s notable representations include:
Representing Ingevity in its appeal to the Federal Circuit of a patent infringement case against BASF and BASF’s antitrust counterclaims.
Representing Medytox in its appeal to the Federal Circuit of the final determination issued by the ITC in an action against Hugel, a global medical aesthetics company.
Representing First Solar as plaintiff in patent infringement litigation against JinkoSolar (“Jinko”), a Chinese solar module manufacturer, and its subsidiaries alleging Jinko has violated one of First Solar’s patents for TOPCon solar technology.
Secured favorable settlements for Truist Bank in patent infringement litigation brought by United Services Automobile Association (“USAA”) in Texas federal court concerning patents that relate to remote check deposits for mobile banking, and in associated IPR proceedings.
Represented Amgen in litigation concerning its introduction of a biosimilar to AbbVie’s biologic drug, Humira®—one of the world’s largest‑selling drugs—in one of the first cases to proceed under the BPCIA. Amgen reached a global settlement with AbbVie that enabled Amgen to market the first approved biosimilar to Humira® in the U.S. and Europe.
Won a jury verdict for Amgen in a patent infringement case in Delaware federal court against Sanofi and Regeneron relating to Amgen’s patents covering a class of biologic drugs that treat high cholesterol.
Obtained a jury verdict for DRIT, an investment partnership, in a patent licensing dispute against Glaxo Group over the lupus drug Benlysta®.
Ms. Goswami serves as a Vice Chair of the Federal Circuit Bar Association’s PTAB and Trademark Trial and Appeal Board (TTAB) Committee, and has previously served as Chair of the Patents Committee of the New York City Bar Association and on Law360’s Life Sciences Editorial Advisory Board. She is a member of the Diversity Committee of the PTAB Bar Association and a Director of the South Asian Bar Association of New York.
Ms. Goswami has been recognized by numerous publications. In 2024, The American Lawyer named her a finalist for its “Young Lawyer of the Year—Litigation” award. She was named a 2023 "Rising Star" by The New York Law Journal, and Benchmark Litigation has recognized her as a "Future Star" and named her to its “40 & Under List.” For her "deep grasp of complex patents" in patent litigation work, Ms. Goswami has been ranked by Chambers USA as a leading intellectual property lawyer and repeatedly recognized by IAM Patent 1000 and The Legal 500 US, including as a “Next Generation Partner.” She has also been named to Lawdragon’s “500 Leading Global IP Lawyers,” “500 Leading Litigators in America” and “500 X – The Next Generation” lists. In 2022, Ms. Goswami received LMG Life Sciences’ “US Rising Star – Intellectual Property” award and Euromoney Legal Media Group’s Rising Star Award for “Best in Patent,” and she was named to Patexia Insight’s list of Top IPR Attorneys of 2022.
Ms. Goswami was born in Washington, D.C. She received a B.S.E. in Chemical Engineering from Princeton University in 2009 and obtained certificates (minors) in Engineering Biology and Materials Science. At Princeton, she was awarded the inaugural leadership prize in Materials Science and Engineering. She received a J.D. magna cum laude from New York University School of Law in 2012, where she was a Florence Allen Scholar, a Senior Editor of the Journal of Intellectual Property & Entertainment Law and was elected to the Order of the Coif. At NYU, she was awarded the Walter J. Derenberg Prize in Copyright Law. She also received the Sidney B. Williams, Jr. scholarship from the Foundation for Advancement of Diversity in IP Law.
Ms. Goswami joined Cravath in 2012. She served as a law clerk to Hon. Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit in 2013. She rejoined Cravath in 2014 and was elected a partner in 2019. Ms. Goswami is a partner liaison to the South Asian Affinity Group.
Ms. Goswami regularly leads patent infringement litigation across various industries—including life sciences, technology and financial services—and has deep experience in intellectual property strategy and management. In recognition of this work, IAM Patent 1000 points to her “exceptional command of the law, technical dexterity, intellect and positivity.” The publication has also noted that she is “extremely strategic and detail‑oriented and knows how to position cases to maximise chances of success.”
Ms. Goswami’s notable representations include:
Representing Ingevity in its appeal to the Federal Circuit of a patent infringement case against BASF and BASF’s antitrust counterclaims.
Representing Medytox in its appeal to the Federal Circuit of the final determination issued by the ITC in an action against Hugel, a global medical aesthetics company.
Representing First Solar as plaintiff in patent infringement litigation against JinkoSolar (“Jinko”), a Chinese solar module manufacturer, and its subsidiaries alleging Jinko has violated one of First Solar’s patents for TOPCon solar technology.
Secured favorable settlements for Truist Bank in patent infringement litigation brought by United Services Automobile Association (“USAA”) in Texas federal court concerning patents that relate to remote check deposits for mobile banking, and in associated IPR proceedings.
Represented Amgen in litigation concerning its introduction of a biosimilar to AbbVie’s biologic drug, Humira®—one of the world’s largest‑selling drugs—in one of the first cases to proceed under the BPCIA. Amgen reached a global settlement with AbbVie that enabled Amgen to market the first approved biosimilar to Humira® in the U.S. and Europe.
Won a jury verdict for Amgen in a patent infringement case in Delaware federal court against Sanofi and Regeneron relating to Amgen’s patents covering a class of biologic drugs that treat high cholesterol.
Obtained a jury verdict for DRIT, an investment partnership, in a patent licensing dispute against Glaxo Group over the lupus drug Benlysta®.
Ms. Goswami serves as a Vice Chair of the Federal Circuit Bar Association’s PTAB and Trademark Trial and Appeal Board (TTAB) Committee, and has previously served as Chair of the Patents Committee of the New York City Bar Association and on Law360’s Life Sciences Editorial Advisory Board. She is a member of the Diversity Committee of the PTAB Bar Association and a Director of the South Asian Bar Association of New York.
Ms. Goswami has been recognized by numerous publications. In 2024, The American Lawyer named her a finalist for its “Young Lawyer of the Year—Litigation” award. She was named a 2023 "Rising Star" by The New York Law Journal, and Benchmark Litigation has recognized her as a "Future Star" and named her to its “40 & Under List.” For her "deep grasp of complex patents" in patent litigation work, Ms. Goswami has been ranked by Chambers USA as a leading intellectual property lawyer and repeatedly recognized by IAM Patent 1000 and The Legal 500 US, including as a “Next Generation Partner.” She has also been named to Lawdragon’s “500 Leading Global IP Lawyers,” “500 Leading Litigators in America” and “500 X – The Next Generation” lists. In 2022, Ms. Goswami received LMG Life Sciences’ “US Rising Star – Intellectual Property” award and Euromoney Legal Media Group’s Rising Star Award for “Best in Patent,” and she was named to Patexia Insight’s list of Top IPR Attorneys of 2022.
Ms. Goswami was born in Washington, D.C. She received a B.S.E. in Chemical Engineering from Princeton University in 2009 and obtained certificates (minors) in Engineering Biology and Materials Science. At Princeton, she was awarded the inaugural leadership prize in Materials Science and Engineering. She received a J.D. magna cum laude from New York University School of Law in 2012, where she was a Florence Allen Scholar, a Senior Editor of the Journal of Intellectual Property & Entertainment Law and was elected to the Order of the Coif. At NYU, she was awarded the Walter J. Derenberg Prize in Copyright Law. She also received the Sidney B. Williams, Jr. scholarship from the Foundation for Advancement of Diversity in IP Law.
Ms. Goswami joined Cravath in 2012. She served as a law clerk to Hon. Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit in 2013. She rejoined Cravath in 2014 and was elected a partner in 2019. Ms. Goswami is a partner liaison to the South Asian Affinity Group.
Federal Circuit Bar Association, PTAB and TTAB Committee
New York City Bar Association, Patents Committee
PTAB Bar Association, Diversity Committee
South Asian Bar Association of New York
Law360
The American Lawyer
Benchmark Litigation
Chambers USA
Euromoney Legal Media Group
Intellectual Asset Management
Lawdragon
The Legal 500 US
New York Law Journal
Deals & Cases
October 17, 2024
On October 15, 2024, the United States Court of Appeals for the Federal Circuit affirmed an inter partes review (“IPR”) decision by the Patent Trial and Appeal Board (“PTAB”) in favor of Cravath client ADT Inc., invalidating all claims of a patent at issue in litigation brought by Vivint, Inc.
Activities
June 30, 2025
On June 20, 2025, Cravath partner Sharonmoyee Goswami participated in the 2025 SABA North American Annual Conference, an annual gathering of South Asian attorneys, judges, general counsel, law firm leaders and public officials, which was hosted by the South Asian Bar Association of North America from June 19‑22 in Denver, Colorado. Sharon spoke on a panel entitled “Mastering Expert Testimony in Patent Trials: Strategies for Persuasion and Clarity Before a Jury,” where she also demonstrated a mock direct and redirect examination of a technical expert.
Activities
May 08, 2025
On May 7, 2025, Cravath partner Sharonmoyee Goswami participated in the 7th annual Life Sciences Patent Network North America–Spring Conference, which was hosted by Life Sciences Intellectual Property Review from May 6‑7 in Boston. The conference hosted law firms, in‑house patent counsel and executives from pharmaceutical and biotech companies to discuss the latest legal rulings, legislative changes and strategic approaches transforming the life sciences IP landscape. Sharon spoke on a panel entitled “Patenting Women’s Health: The Rise of Femtech,” which reviewed topics about patenting products and services designed to support women’s health, including how to overcome eligibility hurdles for biomarkers and addressing divided infringement issues for diagnostics.
Activities
April 25, 2025
On April 25, 2025, Cravath partners Sasha Rosenthal‑Larrea and Sharonmoyee Goswami participated in Fordham Law School’s 32nd Annual Intellectual Property Law & Policy Conference, which took place from April 24‑25 in New York. The conference convened experts across the public and private sectors to discuss developments in the IP law and policy space. Sasha spoke on a panel entitled “Artificial Intelligence” during a session on copyright law, and Sharon spoke on a panel entitled “Patents & Remedies” during a session on patent law.
Activities
April 15, 2025
On April 3, 2025, Cravath partner Sharonmoyee Goswami led “Protect, Scale, Invest: The IP Playbook for Sustainability Leaders,” an event co‑hosted by Cravath in New York. Sharon was featured in a fireside chat for a discussion on strategically leveraging intellectual property to drive value and protect innovation in the energy transition market, including optimizing IP portfolios, scaling innovation in an evolving regulatory landscape, handling potential IP litigation, navigating IP risks and opportunities in transactions and understanding legal and economic trends.
Activities
March 31, 2025
On March 24, 2025, Cravath partner Sharonmoyee Goswami participated in the Banbury Center at Cold Spring Harbor Laboratory’s Government Challenges to U.S. Patent Rights meeting, which was held from March 23‑26 in Lloyd Harbor, New York. Sharon co‑chaired a session entitled “The Public & Private Sectors - Research Funding.”
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.